https://ir.avalotx.com/news-events-presentations/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_ea697aa916e28469528b0006da59afb9/avalotx/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.avalotx.com/news-events-presentations/press-releases/detail/218/avalo-therapeutics-reports-2025-financial-results-and-recent-business-updates Mon, 23 Mar 26 07:00:00 -0400 https://ir.avalotx.com/news-events-presentations/press-releases/detail/218/avalo-therapeutics-reports-2025-financial-results-and-recent-business-updates https://ir.avalotx.com/news-events-presentations/press-releases/detail/217/avalo-therapeutics-to-participate-in-upcoming-investor-conferences Tue, 24 Feb 26 07:00:00 -0500 https://ir.avalotx.com/news-events-presentations/press-releases/detail/217/avalo-therapeutics-to-participate-in-upcoming-investor-conferences https://ir.avalotx.com/news-events-presentations/press-releases/detail/216/avalo-therapeutics-announces-inducement-grants-to-new-employees-under-nasdaq-listing-rule-5635c4 Wed, 18 Feb 26 16:05:00 -0500 https://ir.avalotx.com/news-events-presentations/press-releases/detail/216/avalo-therapeutics-announces-inducement-grants-to-new-employees-under-nasdaq-listing-rule-5635c4 https://ir.avalotx.com/news-events-presentations/press-releases/detail/215/avalo-therapeutics-to-participate-in-upcoming-investor-conferences Wed, 04 Feb 26 07:00:00 -0500 https://ir.avalotx.com/news-events-presentations/press-releases/detail/215/avalo-therapeutics-to-participate-in-upcoming-investor-conferences https://ir.avalotx.com/news-events-presentations/press-releases/detail/214/avalo-therapeutics-announces-inducement-grants-to-new-employees-under-nasdaq-listing-rule-5635c4 Mon, 17 Nov 25 16:30:00 -0500 https://ir.avalotx.com/news-events-presentations/press-releases/detail/214/avalo-therapeutics-announces-inducement-grants-to-new-employees-under-nasdaq-listing-rule-5635c4 https://ir.avalotx.com/news-events-presentations/press-releases/detail/213/avalo-therapeutics-reports-third-quarter-2025-financial-results-and-recent-business-updates Thu, 06 Nov 25 07:00:00 -0500 https://ir.avalotx.com/news-events-presentations/press-releases/detail/213/avalo-therapeutics-reports-third-quarter-2025-financial-results-and-recent-business-updates https://ir.avalotx.com/news-events-presentations/press-releases/detail/212/avalo-therapeutics-to-participate-in-upcoming-investor-conferences Mon, 03 Nov 25 07:00:00 -0500 https://ir.avalotx.com/news-events-presentations/press-releases/detail/212/avalo-therapeutics-to-participate-in-upcoming-investor-conferences https://ir.avalotx.com/news-events-presentations/press-releases/detail/211/avalo-therapeutics-announces-completion-of-enrollment-in-phase-2-lotus-trial-of-avtx-009-for-the-treatment-of-hidradenitis-suppurativa Wed, 29 Oct 25 07:00:00 -0400 https://ir.avalotx.com/news-events-presentations/press-releases/detail/211/avalo-therapeutics-announces-completion-of-enrollment-in-phase-2-lotus-trial-of-avtx-009-for-the-treatment-of-hidradenitis-suppurativa https://ir.avalotx.com/news-events-presentations/press-releases/detail/210/avalo-therapeutics-expands-leadership-team-with-key-appointments-in-business-development-and-human-resources Wed, 01 Oct 25 07:00:00 -0400 https://ir.avalotx.com/news-events-presentations/press-releases/detail/210/avalo-therapeutics-expands-leadership-team-with-key-appointments-in-business-development-and-human-resources https://ir.avalotx.com/news-events-presentations/press-releases/detail/209/avalo-therapeutics-appoints-kevin-r-lind-to-board-of-directors Mon, 22 Sep 25 07:00:00 -0400 https://ir.avalotx.com/news-events-presentations/press-releases/detail/209/avalo-therapeutics-appoints-kevin-r-lind-to-board-of-directors